Kornitzer Capital Management Inc. KS acquired a new stake in Core Laboratories Inc. (NYSE:CLB - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 35,515 shares of the oil and gas company's stock, valued at approximately $615,000. Kornitzer Capital Management Inc. KS owned approximately 0.08% of Core Laboratories at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Nisa Investment Advisors LLC raised its holdings in shares of Core Laboratories by 2,688.5% in the fourth quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock valued at $42,000 after acquiring an additional 2,339 shares in the last quarter. nVerses Capital LLC bought a new stake in shares of Core Laboratories in the third quarter valued at about $48,000. Isthmus Partners LLC raised its holdings in shares of Core Laboratories by 18.8% in the third quarter. Isthmus Partners LLC now owns 10,620 shares of the oil and gas company's stock valued at $197,000 after acquiring an additional 1,682 shares in the last quarter. Quantbot Technologies LP bought a new stake in shares of Core Laboratories in the third quarter valued at about $211,000. Finally, Integrated Investment Consultants LLC raised its holdings in shares of Core Laboratories by 19.9% in the third quarter. Integrated Investment Consultants LLC now owns 16,290 shares of the oil and gas company's stock valued at $302,000 after acquiring an additional 2,709 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several analysts recently weighed in on the company. Citigroup lifted their price objective on Core Laboratories from $14.00 to $15.00 and gave the company a "sell" rating in a report on Thursday. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $17.25.
View Our Latest Analysis on CLB
Core Laboratories Stock Down 4.4 %
Shares of CLB stock traded down $0.75 during trading hours on Friday, reaching $16.13. 314,757 shares of the company's stock were exchanged, compared to its average volume of 320,984. Core Laboratories Inc. has a 1 year low of $13.82 and a 1 year high of $25.13. The stock has a market cap of $755.13 million, a PE ratio of 24.43, a PEG ratio of 0.99 and a beta of 2.38. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The stock's fifty day moving average price is $17.96 and its two-hundred day moving average price is $18.80.
Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, hitting analysts' consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. Research analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current year.
Core Laboratories Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Monday, February 10th will be issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.25%. The ex-dividend date of this dividend is Monday, February 10th. Core Laboratories's payout ratio is presently 6.06%.
Core Laboratories Company Profile
(
Free Report)
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Stories

Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.